FDA Approves Crisaborole (Eucrisa) for Atopic Dermatitis

The FDA has approved Eucrisa ointment for the treatment of mild to moderate atopic dermatitis (eczema) in patients aged 2 years and older.
FDA Approvals
Source: Medscape
FDA Approves Crisaborole (Eucrisa) for Atopic Dermatitis